O'Toole David D. 4
4 · Abraxis BioScience, Inc. · Filed Feb 5, 2009
Insider Transaction Report
Form 4
O'Toole David D.
CFO & Executive VP
Transactions
- Award
Restricted Stock Units
2009-02-03+1,241→ 1,241 total→ Common Stock (1,241 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Abraxis BioScience common stock.
- [F2]25% of the restricted stock units vest on the date of grant and the remaining units vests in 2 equal installments on January 15, 2010 and January 15, 2011. Vested shares will be delivered to the reporting person on each vesting date.